DCF Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
+42,500
New +$283K 0.06% 87
2026
Q1
Sell
-137,500
Closed -$963K 102
2025
Q4
$963K Buy
137,500
+102,500
+293% +$802K 0.26% 70
2025
Q3
$271K Sell
35,000
-30,000
-46% -$234K 0.09% 84
2025
Q2
$566K Buy
65,000
+12,500
+24% +$90.6K 0.26% 67
2025
Q1
$418K Hold
52,500
0.2% 71
2024
Q4
$477K Hold
52,500
0.23% 72
2024
Q3
$482K Hold
52,500
0.19% 73
2024
Q2
$513K Buy
52,500
+1,100
+2% +$13.4K 0.26% 68
2024
Q1
$776K Buy
+51,400
New +$933K 0.38% 53

Other funds holding TDOC

DCF Advisers's TDOC Position: Q2 2026 in Review

DCF Advisers opened a new position in Teladoc Health (TDOC) in Q2 2026: 42,500 shares worth $360K. The stake represents 0.06% of the portfolio and ranks #87 among its holdings. This is a return to the name: DCF Advisers previously reported a position in TDOC as recently as Q4 2025.

DCF Advisers first reported a position in TDOC in Q1 2024 and has held it in 9 quarters since. The position peaked at $963K in Q4 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • DCF Advisers held 42,500 shares of Teladoc Health worth $360K as of Q2 2026.
  • Teladoc Health was a new DCF Advisers position in Q2 2026.
  • Teladoc Health made up 0.06% of DCF Advisers's portfolio in Q2 2026, its #87 holding.
  • DCF Advisers first reported a position in Teladoc Health in Q1 2024 and has held it in 9 quarters since.
  • DCF Advisers's Teladoc Health position peaked at $963K in Q4 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.